Tau-Associated Neurons
Overview
<table class=“infobox infobox-cell”> <tr> <th class=“infobox-header” colspan=“2”>Tau-Associated Neurons</th> </tr> <tr> <td class=“label”>Taxonomy</td> <td>ID</td> </tr> <tr> <td class=“label”>Allen Brain Cell Atlas</td> <td>Search</td> </tr> <tr> <td class=“label”>Cell Ontology (CL)</td> <td>Search</td> </tr> <tr> <td class=“label”>Human Cell Atlas</td> <td>Search</td> </tr> <tr> <td class=“label”>CellxGene Census</td> <td>Search</td> </tr> </table>
Tau Associated Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Neurons with tau pathology represent the primary cellular correlate of cognitive decline in Alzheimer’s disease (AD). Hyperphosphorylated tau forms neurofibrillary tangles (NFTs) that disrupt neuronal function and lead to cell death.[@mudher2023]
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
Tau Biology
Normal Function
- Microtubule binding: Tau stabilizes axonal microtubules
- Axonal transport: Facilitates vesicle and organelle trafficking
- Neuronal polarity: Maintains axonal identity
- Synaptic function: Modulates postsynaptic density
Pathological Conversion
- Hyperphosphorylation: Abnormal phosphorylation reduces microtubule binding
- Conformational change: AD-tau adopts pathogenic beta-sheet
- Oligomer formation: Soluble toxic oligomers accumulate
- Fibril assembly: Paired helical filaments (PHFs) form NFTs
Vulnerable Neuron Populations
Entorhinal Cortex Layer II
- Earliest involvement: Grid cells affected first (Braak stage I-II)
- Episodic memory: ECII→CA1 pathway disrupted early
- Functional consequence: Memory encoding deficits
CA1 Hippocampal Pyramidal Cells
- NFT burden: High density of tangles
- Synaptic loss: Correlates with cognitive impairment
- Circuit dysfunction: Disrupts hippocampal circuitry
Layer V Cortical Pyramidal Cells
- Connectivity: Pivotal for corticocortical communication
- Tau propagation: Serve as hub for spread
- Dysfunction: Contributes to cortical disconnection
Mechanisms of Neurodegeneration
Loss-of-Function
- Microtubule destabilization: Axonal transport deficits
- Synaptic dysfunction: Pre- and postsynaptic impairment
- Organelle trafficking: Mitochondrial and lysosomal dysfunction
Toxic Gain-of-Function
- Oligomer toxicity: Soluble species are most toxic
- ER stress: UPR activation
- Oxidative stress: ROS accumulation
- Neuroinflammation: Glial activation
Therapeutic Implications
Tau-Targeting Therapies
- Immunotherapies: Anti-tau antibodies (phase 2/3)
- Small molecule inhibitors: Tau aggregation inhibitors
- Oligomer modulators: Stabilize native conformation
- Kinase inhibitors: Target upstream kinases (GSK-3β, CDK5)
Cross-Links
- Tau Protein — Key protein
- Alzheimer’s Disease — Associated disease
- Tau Pathology — Pathological mechanism
- Neurofibrillary Tangles — Pathology
See Also
- Tau Protein — Microtubule-associated protein
- Alzheimer’s Disease — Associated disease
- Tau Pathology — Pathological mechanism
- Neurofibrillary Tangles — Tau inclusions
- Tauopathy — Disease category
- Hyperphosphorylation — Pathological modification
External Links
- PubMed: Tau-Associated Neurons - Literature search
- Alzheimer’s Association - AD research and care
- Cure Alzheimer Fund - AD research funding
Overview
Tau Associated Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.[@braak2022]
Background
The study of Tau Associated Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.[@wang2020]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.[@schoonenboom2024]
References
braak2022, Braak & Del Tredici, NFT staging (2022) (2022) kosik2024, Tau biology and therapy (2024) (2024) mudher2023, Tau function and dysfunction (2023) (2023) schoonenboom2024, Tau immunotherapy trials (2024) (2024) wang2020, Wang & Mandelkow, Tau post-translational modifications (2020) (2020)